319 related articles for article (PubMed ID: 29021448)
21. Peritoneovenous shunting for intractable chylous ascites complicated with lymphangioleiomyomatosis.
Makino Y; Shimanuki Y; Fujiwara N; Morio Y; Sato K; Yoshimoto J; Gunji Y; Suzuki T; Sasaki S; Iwase A; Kawasaki S; Takahashi K; Seyama K
Intern Med; 2008; 47(4):281-5. PubMed ID: 18277030
[TBL] [Abstract][Full Text] [Related]
22. A pleuro-peritoneal communication through the diaphragm affected with lymphangioleiomyomatosis.
Takagi Y; Sato T; Morio Y; Kumasaka T; Mitani K; Miyamoto H; Iwakami S; Kodama Y; Onuma E; Seyama K; Takahashi K
Intern Med; 2010; 49(5):439-45. PubMed ID: 20190480
[TBL] [Abstract][Full Text] [Related]
23. Everolimus treatment of abdominal lymphangioleiomyoma in five women with sporadic lymphangioleiomyomatosis.
Mohammadieh AM; Bowler SD; Silverstone EJ; Glanville AR; Yates DH
Med J Aust; 2013 Jul; 199(2):121-3. PubMed ID: 23879512
[TBL] [Abstract][Full Text] [Related]
24. Resolution of refractory chylous ascites after Kasai portoenterostomy using octreotide.
Hwang JB; Choi SO; Park WH
J Pediatr Surg; 2004 Dec; 39(12):1806-7. PubMed ID: 15616936
[TBL] [Abstract][Full Text] [Related]
25. [A case of idiopathic plasmacytic lymph-adenopathy with polyclonal hyperimmunoglobulinemia (IPL) associated with pleural and peritoneal chylous effusion].
Toyoshima T; Sezai S; Marumo K; Shimizu T; Hirano M; Iwase T; Suzuki T; Goto H; Yoshikawa M
Nihon Naika Gakkai Zasshi; 1989 Dec; 78(12):1795-6. PubMed ID: 2625608
[No Abstract] [Full Text] [Related]
26. Octreotide therapy for the management of refractory chylous ascites after a staging operation for endometrial adenocarcinoma.
Kim EA; Park H; Jeong SG; Lee C; Lee JM; Park CT
J Obstet Gynaecol Res; 2014 Feb; 40(2):622-6. PubMed ID: 24118223
[TBL] [Abstract][Full Text] [Related]
27. Use of sirolimus in the treatment of lymphangioleiomyomatosis: favorable responses in patients with different extrapulmonary manifestations.
Freitas CS; Baldi BG; Araújo MS; Heiden GI; Kairalla RA; Carvalho CR
J Bras Pneumol; 2015; 41(3):275-80. PubMed ID: 26176526
[TBL] [Abstract][Full Text] [Related]
28. Chylous ascites caused by portal vein thrombosis treated with octreotide.
Leong RW; House AK; Jeffrey GP
J Gastroenterol Hepatol; 2003 Oct; 18(10):1211-3. PubMed ID: 12974913
[TBL] [Abstract][Full Text] [Related]
29. OK-432 therapy for chylous pleural effusion or ascites associated with lymphatic malformations.
Ono S; Iwai N; Chiba F; Furukawa T; Fumino S
J Pediatr Surg; 2010 Sep; 45(9):e7-10. PubMed ID: 20850615
[TBL] [Abstract][Full Text] [Related]
30. Postoperative chylous ascites in a neonate treated successfully with octreotide: bile sludge and cholestasis.
Andreou A; Papouli M; Papavasiliou V; Badouraki M
Am J Perinatol; 2005 Nov; 22(8):401-4. PubMed ID: 16283598
[TBL] [Abstract][Full Text] [Related]
31. Functional improvements in patients with lymphangioleiomyomatosis after sirolimus: an observational study.
Zhan Y; Shen L; Xu W; Wu X; Zhang W; Wang J; Li X; Yang Y; Tian X; Xu KF
Orphanet J Rare Dis; 2018 Feb; 13(1):34. PubMed ID: 29458386
[TBL] [Abstract][Full Text] [Related]
32. Successful management of chylous ascites with total parenteral nutrition and octreotide in children.
Yang C; Zhang J; Wang S; Li CC; Kong XR; Zhao Z
Nutr Hosp; 2013 Nov; 28(6):2124-7. PubMed ID: 24506391
[TBL] [Abstract][Full Text] [Related]
33. [Postoperative refractory chylothorax which was improved by octreotide acetate].
Gabe A; Seki M; Taira N; Katsura M; Ishida T; Kang Y; Kubota T; Yamashiro T; Uehara T; Sunagawa T; Ohkubo K
Kyobu Geka; 2012 Mar; 65(3):230-3. PubMed ID: 22374601
[TBL] [Abstract][Full Text] [Related]
34. Cytologic, immunocytochemical and ultrastructural characterization of lymphangioleiomyomatosis cell clusters in chylous effusions of patients with lymphangioleiomyomatosis.
Mitani K; Kumasaka T; Takemura H; Hayashi T; Gunji Y; Kunogi M; Akiyoshi T; Takahashi K; Suda K; Seyama K
Acta Cytol; 2009; 53(4):402-9. PubMed ID: 19697724
[TBL] [Abstract][Full Text] [Related]
35. Sirolimus decreases circulating lymphangioleiomyomatosis cells in patients with lymphangioleiomyomatosis.
Cai X; Pacheco-Rodriguez G; Haughey M; Samsel L; Xu S; Wu HP; McCoy JP; Stylianou M; Darling TN; Moss J
Chest; 2014 Jan; 145(1):108-112. PubMed ID: 24051985
[TBL] [Abstract][Full Text] [Related]
36. Octreotide therapy for chylous ascites in a chronic dialysis patient.
Lee PH; Lin CL; Lai PC; Yang CW
Nephrology (Carlton); 2005 Aug; 10(4):344-7. PubMed ID: 16109079
[TBL] [Abstract][Full Text] [Related]
37. Chylous ascites after a living-donor liver graft, effectively treated in a child with octreotide.
Ünlüsoy Aksu A; Demirtaş Z; Eğritaş Gürkan Ö; Dalgıç B; Sözen H; Dalgıç A
Exp Clin Transplant; 2014 Mar; 12 Suppl 1():173-4. PubMed ID: 24635821
[TBL] [Abstract][Full Text] [Related]
38. The effectiveness of the treatment of octreotide on chylous ascites after liver cirrhosis.
Zhou DX; Zhou HB; Wang Q; Zou SS; Wang H; Hu HP
Dig Dis Sci; 2009 Aug; 54(8):1783-8. PubMed ID: 19051030
[TBL] [Abstract][Full Text] [Related]
39. Successful treatment of a patient with chyluria due to lymphangioleiomyomatosis using sirolimus.
Sakaue T; Tominaga M; Niizeki T; Zaizen Y; Matsukuma K; Koganemaru M; Hoshino T; Torimura T
Respir Med Case Rep; 2018; 23():86-89. PubMed ID: 29349035
[TBL] [Abstract][Full Text] [Related]
40. [Octreotide treatment for postoperative chylous ascites in an adult].
Senosiain Lalastra C; Martínez González J; Mesonero Gismero F; Moreira Vicente V
Gastroenterol Hepatol; 2012 Oct; 35(8):567-71. PubMed ID: 22608492
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
